{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:05Z","timestamp":1788970385080,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anndiagpath.2026.152696","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:41:29Z","timestamp":1784130089000},"page":"152696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The application value of serous cavity effusion supernatant in multi-driver gene detection for non-small cell lung cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Lvli","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2026.152696_bb0005","first-page":"S463","article-title":"The pivotal role of pathology in the management of lung cancer","volume":"5","author":"Davidson","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung Cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0015","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0007-2017","article-title":"Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens","volume":"26","author":"Bubendorf","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cyt.13485","article-title":"Liquid biopsy in solid tumours: an overview","volume":"36","author":"Pisapia","year":"2025","journal-title":"Cytopathology"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113112","article-title":"Implementing ctDNA analysis in the clinic: challenges and opportunities in non-small cell lung cancer","volume":"12","author":"Gobbini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0030","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1158\/1078-0432.CCR-23-3321","article-title":"Measurement of ctDNA tumor fraction identifies informative negative liquid biopsy results and informs value of tissue confirmation","volume":"30","author":"Rolfo","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4143\/crt.2023.446","article-title":"Utilizing plasma circulating tumor DNA sequencing for precision medicine in the management of solid cancers","volume":"55","author":"Cha","year":"2023","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/dc.25143","article-title":"Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer","volume":"51","author":"Lin","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2026.109463","article-title":"Study on NGS-based molecular profiling of malignant pleural effusion supernatant cfDNA in guiding targeted therapy for non-small cell lung cancer","volume":"217","author":"Wang","year":"2026","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10040206","article-title":"Molecular profiling of malignant pleural effusions with next generation sequencing (NGS): evidence that supports its role in cancer management","volume":"10","author":"Grigoriadou","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0055","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00016-2019","article-title":"Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions","volume":"5","author":"Hummelink","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70197","article-title":"Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non-small cell lung cancer patients","volume":"13","author":"Ma","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamaoncol.2022.6109","article-title":"Testing for EGFR variants in pleural and pericardial effusion cell-free DNA in patients with non-small cell lung cancer","volume":"9","author":"Lee","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0070","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/1759-7714.13201","article-title":"Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ygyno.2021.06.028","article-title":"Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer","volume":"162","author":"Werner","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cyt.12943","article-title":"DNA ploidy measurement and human papillomavirus in abnormal cervical cytology","volume":"32","author":"Costa","year":"2021","journal-title":"Cytopathology"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0085","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.7150\/jca.38615","article-title":"The correlation between EGFR mutation status and DNA content of lung adenocarcinoma cells in pleural effusion","volume":"11","author":"Du","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0090","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.12669\/pjms.41.11.11655","article-title":"Expression of PD-L1 in pleural effusion of advanced lung adenocarcinoma and its relationship with DNA ploidy","volume":"41","author":"Wu","year":"2025","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0095","article-title":"Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: a systematic review and meta-analysis","volume":"14","author":"Lee","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11523-012-0241-x","article-title":"Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer","volume":"8","author":"Shimizu","year":"2013","journal-title":"Target Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1116809","article-title":"Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer","volume":"13","author":"Fang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.662312","article-title":"Next-generation sequencing of cell-free DNA extracted from pleural effusion supernatant: applications and challenges","volume":"8","author":"Patel","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0115","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jtd.2018.04.125","article-title":"Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens","volume":"10","author":"Liu","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0120","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.2025.17695","article-title":"Lung cancer in nonsmoking individuals: a review","volume":"334","author":"Murphy","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","article-title":"A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)","volume":"9","author":"Shi","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32030146","article-title":"Lung cancer: targeted therapy in 2025","volume":"32","author":"Bouchard","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00164","article-title":"A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability","volume":"3","author":"Orr","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020342","article-title":"Understanding how genetic mutations collaborate with genomic instability in cancer","volume":"10","author":"Jilderda","year":"2021","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.anndiagpath.2026.152696_bb0145","article-title":"Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0150","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"Kustanovich","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0155","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1111\/cas.15084","article-title":"Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers","volume":"112","author":"Hasegawa","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2026.152696_bb0160","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2147\/TCRM.S542338","article-title":"Lung cancer diagnosis and prognostic monitoring through cell-free RNA via liquid biopsy","volume":"21","author":"Pan","year":"2025","journal-title":"Ther Clin Risk Manag"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:29Z","timestamp":1788967889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S1092913426000924"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152696","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The application value of serous cavity effusion supernatant in multi-driver gene detection for non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152696"}}